arrow_back Back to App

Protecting Drug Intellectual Property: Prohibiting Patent Waiver Support

This act aims to protect American medical innovations, especially in the context of the pandemic. It prohibits the use of public funds to support proposals for waiving intellectual property rights for COVID-19 drugs and vaccines at the World Trade Organization. This is intended to ensure that companies continue to invest in developing new therapies, which may affect the availability and cost of future medications.
Key points
Prohibits supporting the waiver of patent rights for COVID-19 drugs and vaccines in international forums.
Aims to protect innovation in the U.S. pharmaceutical industry and encourage further research.
May impact global access to drugs and vaccines by maintaining the current patent protection system.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1683
Sponsor: Sen. Scott, Tim [R-SC]
Process start date: 2021-05-18